Studies on HBcAg-rBlo t 5-21 Fusion Protein Vaccine That Alleviates < em > Blomia tropicalis < /em > Airway Inflammation
CONCLUSION: HBcAg-rBlo t 5-21, a protein vaccine containing both the hepatitis B core antigen and the Blomia tropicalis fusion allergen rBlo t 5-21, could be a suitable vaccination for preventing allergy disorders caused by Blomia tropicalis.PMID:36424919 | PMC:PMC9680538 | DOI:10.2147/JIR.S380526
Source: Cell Research - Category: Cytology Authors: Yechun Pei Zhengpan Xiao Shuangshuang Wei Meiqi Peng Chenghui Luo Dayong Wang Source Type: research
More News: Allergy | Allergy & Immunology | Anaphylactic Shock | Asthma | Cytology | Hay Fever | Hepatitis | Hepatitis B | Hepatitis Vaccine | Study | Vaccines